Ginger Supplementation to Modify Ghrelin Levels and Gut Function in Parkinsons Disease and REM Sleep Behaviour Disorder
Led by Cambridge University Hospitals NHS Foundation Trust · Updated on 2026-10-21
72
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying whether ginger supplements can increase ghrelin, a hormone that stimulates hunger and is found at lower levels in people with Parkinsons disease PD and REM Sleep Behaviour Disorder RBD. The study includes three groups of participants those with PD, those with RBD, and healthy individuals of similar age and sex. The goal is to understand if ginger can raise ghrelin levels in a dose-related way and potentially reduce inflammation and improve gut symptoms in PD.
Participants will be randomly assigned to take one of two doses of ginger root extract capsules daily for 12 weeks either 0.24g or 0.48g. The ginger capsules are recognized as safe by the FDA and taken twice daily morning and night. The study includes up to four visits, with assessments before, during, and after the supplementation period, including blood tests, clinical and cognitive evaluations, and home gut function tests.
Participants will attend screening to check eligibility and baseline measures, then take daily supplements for 12 weeks while being monitored for ghrelin levels, inflammation, and gut function. A final follow-up visit occurs four weeks after stopping the supplements to see if any effects continue. Researchers will track supplement adherence, side effects, and changes in blood markers over the study period, which lasts about 16 weeks in total.
CONDITIONS
Brief Title
Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson's Disease
Research Team
M
Marta Camacho, PhD
I
Imran Waggan, MBBS, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Cambridge University Hospitals NHS Foundation Trust
Lead Sponsor
Swansea University
Collaborating Sponsor
Who Can Participate
Age: 55Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Age 55 years or older
For Parkinson's disease group: meet Movement Disorder Society criteria for Idiopathic Parkinson's disease
For REM Sleep Behaviour Disorder group: diagnosis confirmed by polysomnography and prodromal Parkinson's disease probability score of 80% or above on the Movement Disorders Society calculator
For control group: healthy individuals aged 55 years or older
You will not qualify if you...
Not explicitly provided in the source data
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Up to four visits including baseline assessments and eligibility checks
Treatment
Duration - 12 weeks
Participants take daily ginger supplements at one of two dose levels for 12 weeks while being monitored.
Daily supplementation with study visits for assessments
Follow-up
Duration - 4 weeks
Participants are evaluated four weeks after stopping supplements to assess lasting effects on ghrelin levels, gut function, and inflammation.
One follow-up visit
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Similar Trials
Multimodal Study of Early Parkinsons Disease Signs in People with REM Sleep Behavior Disorder and Controls
Study of Parkinsonism and REM Sleep Behavior Disorder Using Multiple Tests
Including Imaging and Clinical Assessments Over 5 Years
In Adults Aged 31 to 79 Years
Exploring Adalimumab to Prevent Neurodegeneration in REM Sleep Behavior Disorder A Randomized Placebo-Controlled Trial
Using Artificial Intelligence and Molecular Imaging to Predict Parkinsons Disease Risk in Adults with REM Sleep Behavior Disorder
Behavioral Therapy to Reduce Nightmares in Adults with REM Sleep Behavior Disorder
Seven Weekly Videoconference Sessions with Family Participation
Study to Detect Alpha-Synuclein Protein in Colon Tissue During Routine Colonoscopy
for People with Parkinsons Disease or REM Sleep Behavior Disorder
D-SPARK A Phase 2 Randomized, Double-Blind, Placebo-Controlled Crossover Trial of D-Serine Supplementation to Slow Parkinsons Disease Progression in Adults Aged 40 to 80
Pilot Study of Accelerated rTMS Using EXOMIND Device for Improving Movement and Thinking in Mild to Moderate Parkinsons Disease in Adults Aged 50 to 90
Study of Mental Imagery With Self-Regulation Versus Exercise on Daily Activities in Parkinsons Disease
Ginger Supplementation to Modify Ghrelin Levels and Gut Function in Parkinsons Disease and REM Sleep Behaviour Disorder
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The effect of ginger (Zingiber officinale) supplementation on clinical, biochemical, and anthropometric parameters in patients with multiple sclerosis: a double-blind randomized controlled trial.
Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease?
Marcus M Unger, Jens C Möller, Katharina Mankel...